R&D Catching the signals sooner: AI’s role in proactive pharmaco... AI is not a replacement for medical judgement. Rather, it enables a human-guided, scientifically grounded approach.
Digital Sponsored AI-enabled pharmacovigilance, with Updesh Dosanjh Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.
Digital Sponsored From Automation to Decision Intelligence: The Next Operating... In this free white paper, IQVIA experts and thought leaders explore the real challenges and bottlenecks in pharmacovigilance today.
Patients Why patient safety doesn't end at approval Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
R&D A practical route through regulatory uncertainty in clinical... Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.
News Parexel buys Vitrana to boost patient safety toolkit Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.